1 not yet recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Not yet recruiting 1 |
Follow Shr-A1811: new trials by email Literature Review of Shr-A1811 trials Research Report on Shr-A1811
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trastuzumab Rezetecan (T-DXh) in HER2+ Breast Cancer With Non-pCR After TCbHP Trastuzumab Rezetecan - Breast Cancer, HER2-positive Breast Cancer | Phase 4 | Not yet recruiting | The First Affiliated Hospital with Nanjing Medical University | 59 | 2026-05-31 | 2026-05-15 |
Breast Neoplasms (1)
The First Affiliated Hospital with Nanjing Medical University (1)